Skip to main content

Lamotrigine

NDC 69918-350 · Nordic Pharma, Inc.

Generic nameLamotrigine
Dosage formTABLET
RouteORAL
Active ingredient(s)LAMOTRIGINE
Strength25 mg/1
Pharmacologic classAnti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]
Marketing categoryANDA

Packages

69918-350-30 — 30 TABLET in 1 BOTTLE (69918-350-30)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

69102-319 — LAMOTRIGINE, 69102-320 — LAMOTRIGINE, 69102-418 — LAMOTRIGINE, 69102-639 — LAMOTRIGINE, 69117-0044 — lamotrigine extended-release, 69117-0045 — lamotrigine extended-release, 69117-0046 — lamotrigine extended-release, 69117-0047 — lamotrigine extended-release, 69117-0048 — lamotrigine extended-release, 69117-0049 — lamotrigine extended-release, 69918-360 — Lamotrigine, 69918-370 — Lamotrigine, 69918-380 — Lamotrigine, 70518-1153 — Lamotrigine, 70518-1479 — Lamotrigine, 70518-1908 — Lamotrigine, 70518-1978 — Lamotrigine, 70518-2343 — Lamotrigine, 70518-2406 — Lamotrigine, 70518-2563 — Lamotrigine, +270 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels